Market closed
Integra LifeSciences/$IART
Integra LifeSciences shares are trading lower after a law firm announced an investigation into claims on behalf of the company's investors.
18 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Integra LifeSciences
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Ticker
$IART
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
4,396
ISIN
US4579852082
Website
IART Metrics
BasicAdvanced
$1B
-
-$0.38
1.27
-
Price and volume
Market cap
$1B
Beta
1.27
52-week high
$32.66
52-week low
$11.60
Average daily volume
1.1M
Financial strength
Current ratio
1.206
Quick ratio
0.572
Long term debt to equity
91.4
Total debt to equity
132.588
Interest coverage (TTM)
2.64%
Management effectiveness
Return on assets (TTM)
3.08%
Return on equity (TTM)
-1.85%
Valuation
Price to revenue (TTM)
0.609
Price to book
0.66
Price to tangible book (TTM)
-1.3
Price to free cash flow (TTM)
-38.833
Growth
Revenue change (TTM)
6.19%
Earnings per share change (TTM)
-174.44%
3-year revenue growth (CAGR)
1.38%
3-year earnings per share growth (CAGR)
-40.96%
What the Analysts think about IART
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Integra LifeSciences stock.
IART Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
IART Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
IART News
AllArticlesVideos
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
Accesswire·15 minutes ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
GlobeNewsWire·22 hours ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
Accesswire·3 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Integra LifeSciences stock?
Integra LifeSciences (IART) has a market cap of $1B as of May 10, 2025.
What is the P/E ratio for Integra LifeSciences stock?
The price to earnings (P/E) ratio for Integra LifeSciences (IART) stock is 0 as of May 10, 2025.
Does Integra LifeSciences stock pay dividends?
No, Integra LifeSciences (IART) stock does not pay dividends to its shareholders as of May 10, 2025.
When is the next Integra LifeSciences dividend payment date?
Integra LifeSciences (IART) stock does not pay dividends to its shareholders.
What is the beta indicator for Integra LifeSciences?
Integra LifeSciences (IART) has a beta rating of 1.27. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.